208 related articles for article (PubMed ID: 30712125)
21. The interplay of dendritic cell subsets in systemic lupus erythematosus.
Palucka AK; Banchereau J; Blanco P; Pascual V
Immunol Cell Biol; 2002 Oct; 80(5):484-8. PubMed ID: 12225385
[TBL] [Abstract][Full Text] [Related]
22. Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus.
Duffau P; Seneschal J; Nicco C; Richez C; Lazaro E; Douchet I; Bordes C; Viallard JF; Goulvestre C; Pellegrin JL; Weil B; Moreau JF; Batteux F; Blanco P
Sci Transl Med; 2010 Sep; 2(47):47ra63. PubMed ID: 20811042
[TBL] [Abstract][Full Text] [Related]
23. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies.
Scheinecker C; Zwölfer B; Köller M; Männer G; Smolen JS
Arthritis Rheum; 2001 Apr; 44(4):856-65. PubMed ID: 11315925
[TBL] [Abstract][Full Text] [Related]
24. MicroRNAs in the key events of systemic lupus erythematosus pathogenesis.
Husakova M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):327-42. PubMed ID: 27003314
[TBL] [Abstract][Full Text] [Related]
25. Modulation of human Th17 cell responses through complement receptor 3 (CD11 b/CD18) ligation on monocyte-derived dendritic cells.
Nowatzky J; Manches O; Khan SA; Godefroy E; Bhardwaj N
J Autoimmun; 2018 Aug; 92():57-66. PubMed ID: 29908907
[TBL] [Abstract][Full Text] [Related]
26. New insights into the immunopathogenesis of systemic lupus erythematosus.
Tsokos GC; Lo MS; Costa Reis P; Sullivan KE
Nat Rev Rheumatol; 2016 Nov; 12(12):716-730. PubMed ID: 27872476
[TBL] [Abstract][Full Text] [Related]
27. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes.
Boulé MW; Broughton C; Mackay F; Akira S; Marshak-Rothstein A; Rifkin IR
J Exp Med; 2004 Jun; 199(12):1631-40. PubMed ID: 15197227
[TBL] [Abstract][Full Text] [Related]
28. A compass that points to lupus: genetic studies on type I interferon pathway.
Kyogoku C; Tsuchiya N
Genes Immun; 2007 Sep; 8(6):445-55. PubMed ID: 17581625
[TBL] [Abstract][Full Text] [Related]
29. [Fcγ receptor and systemic autoimmune disease].
Amano H
Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(1):1-7. PubMed ID: 21372507
[TBL] [Abstract][Full Text] [Related]
30. FcgammaRIIB, FcgammaRIIIB, and systemic lupus erythematosus.
Niederer HA; Clatworthy MR; Willcocks LC; Smith KG
Ann N Y Acad Sci; 2010 Jan; 1183():69-88. PubMed ID: 20146709
[TBL] [Abstract][Full Text] [Related]
31. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.
Mohan C; Putterman C
Nat Rev Nephrol; 2015 Jun; 11(6):329-41. PubMed ID: 25825084
[TBL] [Abstract][Full Text] [Related]
32. Intravenous immunoglobulin abrogates dendritic cell differentiation induced by interferon-alpha present in serum from patients with systemic lupus erythematosus.
Bayry J; Lacroix-Desmazes S; Delignat S; Mouthon L; Weill B; Kazatchkine MD; Kaveri SV
Arthritis Rheum; 2003 Dec; 48(12):3497-502. PubMed ID: 14674000
[TBL] [Abstract][Full Text] [Related]
33. Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus.
Jüptner M; Flachsbart F; Caliebe A; Lieb W; Schreiber S; Zeuner R; Franke A; Schröder JO
Lupus; 2018 Apr; 27(4):600-609. PubMed ID: 29050534
[TBL] [Abstract][Full Text] [Related]
34. Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms.
Pellerin A; Otero K; Czerkowicz JM; Kerns HM; Shapiro RI; Ranger AM; Otipoby KL; Taylor FR; Cameron TO; Viney JL; Rabah D
EMBO Mol Med; 2015 Apr; 7(4):464-76. PubMed ID: 25762615
[TBL] [Abstract][Full Text] [Related]
35. Current advances in the human lupus genetics.
Shen N; Tsao BP
Curr Rheumatol Rep; 2004 Oct; 6(5):391-8. PubMed ID: 15355752
[TBL] [Abstract][Full Text] [Related]
36. The genetic contribution to systemic lupus erythematosus.
Criswell LA
Bull NYU Hosp Jt Dis; 2008; 66(3):176-83. PubMed ID: 18937628
[TBL] [Abstract][Full Text] [Related]
37. Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG.
Båve U; Magnusson M; Eloranta ML; Perers A; Alm GV; Rönnblom L
J Immunol; 2003 Sep; 171(6):3296-302. PubMed ID: 12960360
[TBL] [Abstract][Full Text] [Related]
38. Genetic susceptibility to SLE: recent progress from GWAS.
Cui Y; Sheng Y; Zhang X
J Autoimmun; 2013 Mar; 41():25-33. PubMed ID: 23395425
[TBL] [Abstract][Full Text] [Related]
39. The Post-GWAS Era: How to Validate the Contribution of Gene Variants in Lupus.
Fike AJ; Elcheva I; Rahman ZSM
Curr Rheumatol Rep; 2019 Jan; 21(1):3. PubMed ID: 30673885
[TBL] [Abstract][Full Text] [Related]
40. Interferon-α abrogates the suppressive effect of apoptotic cells on dendritic cells in an in vitro model of systemic lupus erythematosus pathogenesis.
Abeler-Dörner L; Rieger CC; Berger B; Weyd H; Gräf D; Pfrang S; Tarner IH; Schwarting A; Lorenz HM; Müller-Ladner U; Krammer PH; Kuhn A
J Rheumatol; 2013 Oct; 40(10):1683-96. PubMed ID: 24037549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
